It is increasingly recognized that next-generation probiotics (NGPs) play important roles in the treatment of different kinds of diseases. As a leader in developing and producing novel NGPs, Creative Biolabs is committed to providing overall solutions for NGP drug discovery, focusing on NGPs isolation and identification, process development & optimization, NGPs analyses, and cGMP manufacturing for probiotics industrialization. We will work with you at all stages of your NGP development projects.
NGPs are closely related to the development of intra- and extra-intestinal, chronic inflammation-related diseases such as colitis, obesity/metabolic syndromes, diabetes mellitus, liver diseases, cardiovascular diseases, neurodegenerative diseases, and cancers. Therefore, NGPs have been considered as effective bioindicators and actors of human health. Moreover, the interactions between the gastrointestinal microbiome (NGPs) and immune milieu have been investigated as predictors and influencers of disease immunotherapy.
NGPs play important roles in sustaining or reconstructing the homeostasis of intestinal microbiota, so they show great promise in clinical therapeutics. With extensive expertise in the human probiotic field, Creative Biolabs is dedicated to developing the NGPs to establish, restore, and maintain a healthy gut microbiome. If you are interested in our services, please feel free to contact us.
For Research Use Only. Not intended for use in food manufacturing or medical procedures (diagnostics or therapeutics). Do Not Use in Humans.
For Research Use Only. Not intended for use in food manufacturing or medical procedures (diagnostics or therapeutics). Do Not Use in Humans.
Copyright © 2024 Creative Biolabs. All Rights Reserved.